Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of EUR 177.08 billion. The enterprise value is 216.27 billion.

Market Cap	177.08B
Enterprise Value	216.27B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Feb 13, 2026

Share Statistics

Current Share Class	539.07M
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	81.83%
Float	537.72M

Valuation Ratios

The trailing PE ratio is 26.96 and the forward PE ratio is 17.31.

PE Ratio	26.96
Forward PE	17.31
PS Ratio	5.66
PB Ratio	24.01
P/TBV Ratio	n/a
P/FCF Ratio	25.67
P/OCF Ratio	20.88
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.15, with an EV/FCF ratio of 31.35.

EV / Earnings	32.93
EV / Sales	6.95
EV / EBITDA	15.15
EV / EBIT	22.08
EV / FCF	31.35

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 6.40.

Current Ratio	1.14
Quick Ratio	0.73
Debt / Equity	6.40
Debt / EBITDA	3.29
Debt / FCF	6.84
Interest Coverage	3.66

Financial Efficiency

Return on equity (ROE) is 106.10% and return on invested capital (ROIC) is 18.12%.

Return on Equity (ROE)	106.10%
Return on Assets (ROA)	7.93%
Return on Invested Capital (ROIC)	18.12%
Return on Capital Employed (ROCE)	17.78%
Weighted Average Cost of Capital (WACC)	6.44%
Revenue Per Employee	993,677
Profits Per Employee	208,491
Employee Count	31,500
Asset Turnover	0.40
Inventory Turnover	1.62

Taxes

In the past 12 months, Amgen has paid 1.08 billion in taxes.

Income Tax	1.08B
Effective Tax Rate	14.09%

Stock Price Statistics

The stock price has increased by +12.57% in the last 52 weeks. The beta is 0.47, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	+12.57%
50-Day Moving Average	295.67
200-Day Moving Average	266.28
Relative Strength Index (RSI)	69.35
Average Volume (20 Days)	943

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.97

Income Statement

In the last 12 months, Amgen had revenue of EUR 31.30 billion and earned 6.57 billion in profits. Earnings per share was 12.12.

Revenue	31.30B
Gross Profit	22.16B
Operating Income	9.86B
Pretax Income	7.64B
Net Income	6.57B
EBITDA	14.15B
EBIT	9.86B
Earnings Per Share (EPS)	12.12

Full Income Statement

Balance Sheet

The company has 7.78 billion in cash and 47.21 billion in debt, giving a net cash position of -39.44 billion.

Cash & Cash Equivalents	7.78B
Total Debt	47.21B
Net Cash	-39.44B
Net Cash Per Share	n/a
Equity (Book Value)	7.37B
Book Value Per Share	13.69
Working Capital	3.04B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.48 billion and capital expenditures -1.58 billion, giving a free cash flow of 6.90 billion.

Operating Cash Flow	8.48B
Capital Expenditures	-1.58B
Free Cash Flow	6.90B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.78%, with operating and profit margins of 31.49% and 20.98%.

Gross Margin	70.78%
Operating Margin	31.49%
Pretax Margin	24.42%
Profit Margin	20.98%
EBITDA Margin	45.22%
EBIT Margin	31.49%
FCF Margin	22.04%

Dividends & Yields

This stock pays an annual dividend of 8.36, which amounts to a dividend yield of 2.54%.

Dividend Per Share	8.36
Dividend Yield	2.54%
Dividend Growth (YoY)	-1.96%
Years of Dividend Growth	15
Payout Ratio	66.45%
Buyback Yield	-0.19%
Shareholder Yield	2.35%
Earnings Yield	3.71%
FCF Yield	3.90%

Dividend Details

Stock Splits

The last stock split was on November 22, 1999. It was a forward split with a ratio of 2.

Last Split Date	Nov 22, 1999
Split Type	Forward
Split Ratio	2

Scores

Amgen has an Altman Z-Score of 1.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.65
Piotroski F-Score	7